Sumoylation of eukaryotic elongation factor 2 is vital for protein stability and anti-apoptotic activity in lung adenocarcinoma cells

Cancer Science

Volumn 102, Issue 8, 2011, Pages 1582-1589

  Chen, Chih Yi ^a,b   Fang, Hsin Yuan ^a,b   Chiou, Shiow Her ^c   Yi, Shih En ^d   Huang, Chih Yang ^c   Chiang, Shu Fen ^c   Chang, Hui Wen ^a   Lin, Tze Yi ^a   Chiang, I Ping ^a,b   Chow, Kuan Chih ^d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c Graduate Institute of Microbiology and Public Health   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ELONGATION FACTOR 2;

ARTICLE; AUTOPHAGY; CARCINOMA CELL; CHEMOSENSITIVITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN STABILITY; SUMOYLATION; TUMOR RECURRENCE;

ADENOCARCINOMA; APOPTOSIS; CELL LINE, TUMOR; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MITOCHONDRIA; PEPTIDE ELONGATION FACTOR 2; PROGNOSIS; PROTEIN STABILITY; SUMOYLATION;

EID: 79960392650     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01975.x     Document Type: Article

References (38)

1. Rosell R, Moran T, Fernanda Salazar M et al. The place of targeted therapies in the management of non-small cell bronchial carcinoma. Molecular markers as predictors of tumor response and survival in lung cancer. Rev Mal Respir 2006; 23: 16S131-6.
2. Hsu NY, Ho HC, Chow KC et al. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. Cancer Res 2001; 61: 2727-31.
3. Chen JT, Lin TS, Chow KC et al. Cigarette smoking induces overexpression of HGF in type II pneumocytes and lung cancer cells. Am J Respir Cell Mol Biol 2006; 34: 264-73.
4. Chen JT, Huang CY, Chiang YY et al. HGF increases cisplatin resistance via down-regulation of AIF in lung cancer cells. Am J Respir Cell Mol Biol 2008; 38: 559-65.
5. Chiang YY, Chen SL, Hsiao YT et al. Nuclear expression of dynamin-related protein 1 in lung adenocarcinomas. Mod Pathol 2009; 22: 1139-50.
6. Fang HY, Chang CL, Hsu SH et al. ATPase family AAA domain-containing 3A is a novel anti-apoptotic factor in lung adenocarcinoma cells. J Cell Sci 2010; 123: 1171-80.
7. Thornton S, Anand N, Purcell D, Lee J. Not just for housekeeping: protein initiation and elongation factors in cell growth and tumorigenesis. J Mol Med 2003; 81: 536-48.
8. Rhoads RE. Protein synthesis, cell growth and oncogenesis. Curr Opin Cell Biol 1991; 3: 1019-24.
9. Anand N, Murthy S, Amann G et al. Protein elongation factor eEF1A2 is a putative oncogene in ovarian cancer. Nat Genet 2002; 31: 301-5.
10. Yoshizawa A, Fukuoka J, Shimizu S et al. Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer. Clin Cancer Res 2010; 16: 240-8.
11. De Benedetti A, Graff JR. eIF-4E expression and its role in malignancies and metastases. Oncogene 2004; 23: 3189-99.
12. Pinke DE, Kalloger SE, Francetic T, Huntsman DG, Lee JM. The prognostic significance of elongation factor eEF1A2 in ovarian cancer. Gynecol Oncol 2008; 108: 561-8.
13. Hagner PR, Schneider A, Gartenhaus RB. Targeting the translational machinery as a novel treatment strategy for hematologic malignancies. Blood 2010; 115: 2127-35.
14. Adams J, Kelso R, Cooley L. The kelch repeat superfamily of proteins: propellers of cell function. Trends Cell Biol 2000; 10: 17-24.
15. Mackie KP, Nairn AC, Hampel G, Lam G, Jaffe EA. Thrombin and histamine stimulate the phosphorylation of elongation factor 2 in human umbilical vein endothelial cells. J Biol Chem 1989; 264: 1748-53.
16. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest 2009; 136: 260-71.
17. Reddel RR, Ke Y, Gerwin BI et al. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 1988; 48: 1904-9.
18. Chan MC, Cheung CY, Chui WH et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005; 6: 135.
19. Remmele W, Schicketanz KH. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol Res Pract 1993; 189: 862-6.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
21. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-70.
22. Wilkinson KD. Protein ubiquitination: a regulatory post-translational modification. Anticancer Drug Des 1987; 2: 211-29.
23. Wilkinson KA, Henley JM. Mechanisms, regulation and consequences of protein sumoylation. Biochem J 2010; 428: 133-45.
24. Mahajan R, Delphin C, Guan T, Gerace L, Melchior F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 1997; 88: 97-107.
25. Martin S, Wilkinson KA, Nishimune A, Henley JM. Emerging extranuclear roles of protein sumoylation in neuronal function and dysfunction. Nat Rev Neurosci 2007; 8: 948-59.
26. Matunis MJ, Coutavas E, Blobel G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol 1996; 135: 1457-70.
27. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 2007; 8: 947-56.
28. Gires O, Münz M, Schaffrik M et al. Profile identification of disease-associated humoral antigens using AMIDA, a novel proteomics-based technology. Cell Mol Life Sci 2004; 61: 1198-207.
29. Suzuki A, Iizuka A, Komiyama M et al. Identification of melanoma antigens using a Serological Proteome Approach (SERPA). Cancer Genomics Proteomics 2010; 7: 17-23.
30. Nakamura J, Aoyagi S, Nanchi I et al. Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle. Int J Oncol 2009; 34: 1181-9.
31. Kim KI, Baek SH. SUMOylation code in cancer development and metastasis. Mol Cells 2006; 22: 247-53.
32. Waterham HR, Koster J, van Roermund CW, Mooyer PA, Wanders RJ, Leonard JV. A lethal defect of mitochondrial and peroxisomal fission. N Engl J Med 2007; 356: 1736-41.
33. Griparic L, van der Wel NN, Orozco IJ, Peters PJ, van der Bliek AM. Loss of the intermembrane space protein Mgm1/OPA1 induces swelling and localized constrictions along the lengths of mitochondria. J Biol Chem 2004; 279: 18792-8.
34. Fannjiang Y, Cheng WC, Lee SJ et al. Mitochondrial fission proteins regulate programmed cell death in yeast. Genes Dev 2004; 18: 2785-97.
35. Rolland SG, Lu Y, David CN, Conradt B. The Bcl-2-like protein CED-9 of C. elegans promotes FZO-1/Mfn1, 2- and EAT-3/Opa1-dependent mitochondrial fusion. J Cell Biol 2009; 186: 525-40.
36. Connolly E, Braunstein S, Formenti S, Schneider RJ. Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells. Mol Cell Biol 2006; 26: 3955-65.
37. Yang Q, Guan KL. Expanding mTOR signaling. Cell Res 2007; 17: 666-81.
38. Chiang YY. Hepatocyte growth factor induces hypoxia-related interleukin-8 expression in lung adenocarcinoma cells. Mol Carcinog 2009; 48: 662-70.